Literature DB >> 12948812

Differential mutagenic, antimutagenic and cytotoxic responses induced by apomorphine and its oxidation product, 8-oxo-apomorphine-semiquinone, in bacteria and yeast.

Jaqueline N Picada1, Angel F Maris, Karina Ckless, Mirian Salvador, Nikita N Khromov-Borisov, João Antonio Pêgas Henriques.   

Abstract

Apomorphine (APO) is considered to be a classical mixed type dopamine D(1) and D(2) receptor agonist. It has been used in the therapy of Parkinson's disease and, more recently, for the treatment of erectile dysfunction. Like other catechols (e.g. dopamine), APO easily autoxidizes, producing quinone and semiquinone derivatives that may lead to the formation of reactive oxygen species and induce neurotoxicity. We assayed mutagenicity, antimutagenicity, and cytotoxicity of these compounds by means of the Salmonella/microsome assay, WP2 Mutoxitest and sensitivity assay in Saccharomyces cerevisiae yeast strains lacking antioxidant defenses. In the absence of S9 mix both compounds Apomorphine and its oxidation derivative, 8-oxo-apomorphine-semiquinone (8-OASQ), both at doses ranging from 20 to 80 microg per plate, induced frameshift mutations in TA98 and TA97 S. typhimurium strains, with 8-OASQ being up to two times more mutagenic. However, for strains which detect oxidative mutagens, 8-OASQ acted as a mutagen while APO was an antimutagen, inhibiting H(2)O(2) and t-BOOH-induced mutagenicity in TA102 S. typhimurium and WP2-derived E. coli strains. The S9 mix inhibited all mutagenic effects, probably either by conjugation of APO and 8-OASQ to proteins or by quenching reactive oxygen species. In sensitivity assays with S. cerevisiae, APO was only clearly cytotoxic to some strains at higher doses (200 and 400 microg/ml), whereas 8-OASQ dose-dependently sensitized all the strains, mainly the mutants lacking catalase (deltactt1), superoxide dismutase (deltasod1) and Yap1 transcription factor (deltayap1), suggesting that 8-OASQ cytotoxicity towards S. cerevisiae results from its pro-oxidant properties. APO also tended to protect S. cerevisiae strains against oxidative damage induced by high concentrations of H(2)O(2) and t-BOOH, while 8-OASQ enhanced pro-oxidant effects and induced adaptation responses to these agents. These results suggest that the 8-OASQ oxidation product of APO might induce cytotoxic and genotoxic effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948812     DOI: 10.1016/s1383-5718(03)00132-3

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  4 in total

1.  Oxidative stress activates FUS1 and RLM1 transcription in the yeast Saccharomyces cerevisiae in an oxidant-dependent Manner.

Authors:  Liliana Staleva; Andrea Hall; Seth J Orlow
Journal:  Mol Biol Cell       Date:  2004-09-22       Impact factor: 4.138

Review 2.  Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.

Authors:  Manon Auffret; Sophie Drapier; Marc Vérin
Journal:  Clin Drug Investig       Date:  2018-04       Impact factor: 2.859

3.  Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging.

Authors:  Chih-Jen Wen; Li-Wen Zhang; Saleh A Al-Suwayeh; Tzu-Chen Yen; Jia-You Fang
Journal:  Int J Nanomedicine       Date:  2012-03-26

4.  Nutritional composition of Eragrostis teff and its association with the observed antimutagenic effects.

Authors:  Maria Clara da Silva Goersch; Laura Schäfer; Marina Tonial; Viviani Ruffo de Oliveira; Alexandre de Barros Falcão Ferraz; Jean Fachini; Juliana Bondan da Silva; Liana Appel Boufleur Niekraszewicz; Carlos Eduardo Rodrigues; Giancarlo Pasquali; Johnny Ferraz Dias; Tarso B Ledur Kist; Jaqueline Nascimento Picada
Journal:  RSC Adv       Date:  2019-01-28       Impact factor: 3.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.